These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1884895)

  • 21. Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors.
    Deberg M; Houssa P; Frank BH; Sodoyez-Goffaux F; Sodoyez JC
    Clin Chem; 1998 Jul; 44(7):1504-13. PubMed ID: 9665430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men.
    Vangipurapu J; Stančáková A; Kuulasmaa T; Kuusisto J; Laakso M
    PLoS One; 2015; 10(4):e0124028. PubMed ID: 25853252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and clinical implications of proinsulin conversion intermediates.
    Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
    J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance.
    Ward WK; LaCava EC; Paquette TL; Beard JC; Wallum BJ; Porte D
    Diabetologia; 1987 Sep; 30(9):698-702. PubMed ID: 3322910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Insulin, proinsulin].
    Tsuchida A; Yazawa M; Imai Y; Kawazu S
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():369-77. PubMed ID: 12355775
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperproinsulinemia in type II diabetes.
    Cohen RM; Nathan DM; Clements RS
    Diabetes Care; 1992 May; 15(5):723-4. PubMed ID: 1516496
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperproinsulinaemia and risk of Type 2 diabetes mellitus in women.
    Schulze MB; Solomon CG; Rifai N; Cohen RM; Sparrow J; Hu FB; Manson JE
    Diabet Med; 2005 Sep; 22(9):1178-84. PubMed ID: 16108846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of proinsulin in human plasma.
    Kitabchi AE
    South Med J; 1972 Jul; 65(7):833-8. PubMed ID: 5038175
    [No Abstract]   [Full Text] [Related]  

  • 29. Normal proinsulin processing despite beta-cell dysfunction in persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis).
    Leibowitz G; Weintrob N; Pikarsky A; Josefsberg Z; Landau H; Glaser B; Hales CN; Cerasi E
    Diabetologia; 1996 Nov; 39(11):1338-44. PubMed ID: 8933002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Yoshioka N; Kuzuya T; Matsuda A; Taniguchi M; Iwamoto Y
    Diabetologia; 1988 Jun; 31(6):355-60. PubMed ID: 3046976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of specific immunoradiometric assay to determine preterm neonatal insulin-glucose relations.
    Hawdon JM; Hubbard M; Hales CN; Clark PM
    Arch Dis Child Fetal Neonatal Ed; 1995 Nov; 73(3):F166-9. PubMed ID: 8535874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperproinsulinemia and proinsulin-to-insulin ratios in Swedish middle-aged men: association with glycemia and insulin resistance but not with family history of diabetes.
    Grill V; Dinesen B; Carlsson S; Efendic S; Pedersen O; Ostenson CG
    Am J Epidemiol; 2002 May; 155(9):834-41. PubMed ID: 11978587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome.
    Mohamed-Ali V; Pinkney JH; Panahloo A; Cwyfan-Hughes S; Holly JM; Yudkin JS
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):221-8. PubMed ID: 10396366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus.
    Deacon CF; Schleser-Mohr S; Ballmann M; Willms B; Conlon JM; Creutzfeldt W
    Acta Endocrinol (Copenh); 1988 Dec; 119(4):549-54. PubMed ID: 3059740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia.
    Birkeland KI; Torjesen PA; Eriksson J; Vaaler S; Groop L
    Diabetes Care; 1994 Nov; 17(11):1307-10. PubMed ID: 7821172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proinsulin level in diabetes mellitus measured by a new immunochemiluminometric assay.
    Wu TJ; Lin CL; Taylor RL; Kao PC
    Ann Clin Lab Sci; 1995; 25(6):467-74. PubMed ID: 8572555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-Resolved Fluorescence Assays for Quantification of Insulin Precursors in Plasma and Serum.
    Taylor K; Halsall I; Guest PC; Burling K
    Methods Mol Biol; 2018; 1735():457-465. PubMed ID: 29380336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance, insulin, proinsulin, and ambulatory blood pressure in type II diabetes.
    Pinkney JH; Mohamed-Ali V; Denver AE; Foster C; Sampson MJ; Yudkin JS
    Hypertension; 1994 Sep; 24(3):362-7. PubMed ID: 8082943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methods for the assessment of peptide precursors. Studies insulin biosynthesis.
    Tager HS; Rubenstein AH; Steiner DF
    Methods Enzymol; 1975; 37():326-45. PubMed ID: 1092957
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemical and biological aspects of insulin and proinsulin.
    Steiner DF; Terris S; Chan SJ; Rubenstein AH
    Acta Med Scand Suppl; 1976; 601():55-107. PubMed ID: 16981321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.